NEI STUDY REVEALS BROAD IMPLICATIONS FOR VISION RESTORATION
A research project that was originally initiated to restore vision loss from dry age-related macular degeneration (AMD) may have broader applicability than originally believed. The research focuses on gene therapy that could treat additional eye diseases, both rare and common.
Funded by the National Eye Institute (NEI), the research uses gold nanoparticles together with light to target specific cells in mouse retina. The scientists involved believe the technology could solve a variety of problems in gene therapy.